The Rise to Immunize™ (RIZE) campaign achieved impressive results in the first year of implementation. A total of 5,078,982 adult vaccines were administered or documented, including:
• 3,799,935 influenza vaccines (19+)
• 182,872 pneumococcal vaccines (66+)
• 586,153 Td/Tdap vaccines (19+)
• 510,022 zoster vaccines (50+)
Over the course of the year, there was a three percent improvement in the bundle measure (patients 66+ vaccinated with influenza, pneumococcal, Td/Tdap, and zoster), which equates to approximately 60,000 additional adults receiving comprehensive immunization care.
Due to our impact on influenza vaccination rates across the country, the National Influenza Immunization Summit recognized RIZE as a National Winner of their 2023 “Influenza Season” Immunization Champion Award.